Literature DB >> 25282390

Reprint of: The Great Beauty of the osteoclast.

Alfredo Cappariello1, Antonio Maurizi2, Vimal Veeriah3, Anna Teti4.   

Abstract

Much has been written recently on osteoclast biology, but this cell type still astonishes scientists with its multifaceted functions and unique properties. The last three decades have seen a change in thinking about the osteoclast, from a cell with a single function, which just destroys the tissue it belongs to, to an "orchestrator" implicated in the concerted regulation of bone turnover. Osteoclasts have unique morphological features, organelle distribution and plasma membrane domain organization. They require polarization to cause extracellular bone breakdown and release of the digested bone matrix products into the circulation. Osteoclasts contribute to the control of skeletal growth and renewal. Alongside other organs, including kidney, gut, thyroid and parathyroid glands, they also affect calcemia and phosphatemia. Osteoclasts are very sensitive to pro-inflammatory stimuli, and studies in the '00s ascertained their tight link with the immune system, bringing about the question why bone needs a cell regulated by the immune system to remove the extracellular matrix components. Recently, osteoclasts have been demonstrated to contribute to the hematopoietic stem cell niche, controlling local calcium concentration and regulating the turnover of factors essential for hematopoietic stem cell mobilization. Finally, osteoclasts are important regulators of osteoblast activity and angiogenesis, both by releasing factors stored in the bone matrix, and secreting "clastokines" that regulate the activity of neighboring cells. All these facets will be discussed in this review article, with the aim of underscoring The Great Beauty of the osteoclast.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Bone formation; Bone resorption; Hematopoiesis; Immune system; Osteoclast

Mesh:

Year:  2014        PMID: 25282390     DOI: 10.1016/j.abb.2014.08.009

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Mechanism of Huangqi Sanxian Decoction Inhibiting Osteoclast Differentiation Based on Network Pharmacology.

Authors:  Jian-Xin Shi; Xiao-Qun Cai; Ze-Hao Zhao; Yu Deng; Zhi-Kun Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

Review 2.  Factors regulating immunoglobulin production by normal and disease-associated plasma cells.

Authors:  David A Jackson; Sherine F Elsawa
Journal:  Biomolecules       Date:  2015-01-21

Review 3.  The Osteoclast in Bone Metastasis: Player and Target.

Authors:  Antonio Maurizi; Nadia Rucci
Journal:  Cancers (Basel)       Date:  2018-06-27       Impact factor: 6.639

Review 4.  Mandibular Bone Loss after Masticatory Muscles Intervention with Botulinum Toxin: An Approach from Basic Research to Clinical Findings.

Authors:  Julián Balanta-Melo; Viviana Toro-Ibacache; Kornelius Kupczik; Sonja Buvinic
Journal:  Toxins (Basel)       Date:  2019-02-01       Impact factor: 4.546

5.  Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells.

Authors:  Frank Zach; Alexandra Mueller; André Gessner
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

Review 6.  Updates on Osteoimmunology: What's New on the Cross-Talk Between Bone and Immune System.

Authors:  Marco Ponzetti; Nadia Rucci
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-18       Impact factor: 5.555

Review 7.  Immune system and bone microenvironment: rationale for targeted cancer therapies.

Authors:  Antonio Gnoni; Oronzo Brunetti; Vito Longo; Angela Calabrese; Antonel-la Argentiero; Roberto Calbi; Giovanni Solimando Antonio; Antonella Licchetta
Journal:  Oncotarget       Date:  2020-01-28

Review 8.  The Role of Extracellular Vesicles (EVs) in the Epigenetic Regulation of Bone Metabolism and Osteoporosis.

Authors:  Maurizio Muraca; Alfredo Cappariello
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

9.  Overexpression of c-Fos reverses osteoprotegerin-mediated suppression of osteoclastogenesis by increasing the Beclin1-induced autophagy.

Authors:  Xishuai Tong; Miaomiao Chen; Ruilong Song; Hongyan Zhao; Jianchun Bian; Jianhong Gu; Zongping Liu
Journal:  J Cell Mol Med       Date:  2020-12-04       Impact factor: 5.295

10.  Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

Authors:  Mattia Capulli; Antonio Maurizi; Luca Ventura; Nadia Rucci; Anna Teti
Journal:  Mol Ther Nucleic Acids       Date:  2015-09-01       Impact factor: 10.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.